These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24859437)
1. Targeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents--an in vitro study. Srinivasan S; Manchanda R; Lei T; Nagesetti A; Fernandez-Fernandez A; McGoron AJ J Photochem Photobiol B; 2014 Jul; 136():81-90. PubMed ID: 24859437 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study. Tang Y; Lei T; Manchanda R; Nagesetti A; Fernandez-Fernandez A; Srinivasan S; McGoron AJ Pharm Res; 2010 Oct; 27(10):2242-53. PubMed ID: 20694526 [TBL] [Abstract][Full Text] [Related]
4. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Saxena V; Sadoqi M; Shao J Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634 [TBL] [Abstract][Full Text] [Related]
5. Fabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted photochemotherapy of breast cancer cells. Lee YH; Chang DS Sci Rep; 2017 Apr; 7():46688. PubMed ID: 28429764 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin. Li F; Sun J; Zhu H; Wen X; Lin C; Shi D Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Chittasupho C; Lirdprapamongkol K; Kewsuwan P; Sarisuta N Eur J Pharm Biopharm; 2014 Oct; 88(2):529-38. PubMed ID: 25119723 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and biological verification of anti-HER2 indocyanine green-doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for targeted photochemotherapy of breast cancer cells. Lee YH; Ma YT J Nanobiotechnology; 2017 May; 15(1):41. PubMed ID: 28521752 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
10. Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells. Tang Y; McGoron AJ J Photochem Photobiol B; 2009 Dec; 97(3):138-44. PubMed ID: 19811928 [TBL] [Abstract][Full Text] [Related]
11. Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy. Zheng M; Yue C; Ma Y; Gong P; Zhao P; Zheng C; Sheng Z; Zhang P; Wang Z; Cai L ACS Nano; 2013 Mar; 7(3):2056-67. PubMed ID: 23413798 [TBL] [Abstract][Full Text] [Related]
12. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer. Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and Indocyanine Green Loaded Hybrid Bicelles for Fluorescence Imaging Guided Synergetic Chemo/Photothermal Therapy. Lin L; Liang X; Xu Y; Yang Y; Li X; Dai Z Bioconjug Chem; 2017 Sep; 28(9):2410-2419. PubMed ID: 28810733 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
15. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells. Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814 [TBL] [Abstract][Full Text] [Related]
16. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform. Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Wang S; Zhang J; Wang Y; Chen M Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968 [TBL] [Abstract][Full Text] [Related]
18. Mn Xi J; Da L; Yang C; Chen R; Gao L; Fan L; Han J Int J Nanomedicine; 2017; 12():3331-3345. PubMed ID: 28479854 [TBL] [Abstract][Full Text] [Related]
19. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells. Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568 [TBL] [Abstract][Full Text] [Related]
20. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Liu SQ; Tong YW; Yang YY Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]